Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV003985182 | SCV004801499 | pathogenic | Developmental and epileptic encephalopathy, 26 | 2020-04-16 | criteria provided, single submitter | clinical testing | The KCNB1 c.682C>T p.(Gln228Ter) nonsense variant is expected to result in the loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. This variant has been identified in a de novo state in an individual with a phenotype consistent with developmental and epileptic encephalopathy (de Kovel et al. 2017; Bar et al. 2020). This variant is not observed in version 2.1.1 of the Genome Aggregation Database. The variant was identified in a de novo state in the proband. Based on the available evidence the c.682C>T p.(Gln228Ter)variant is classified as pathogenic for developmental and epileptic encephalopathy. |